Please login to the form below

Not currently logged in

Teva offloads women's health unit in quickfire deals

TevaThe Israeli pharma group is also set to sell its oncology and pain business

CHMP backs maintenance therapy for Tesaro's Zejula

Swiss biotech's PARP inhibitor recommended for approval in ovarian cancer

Bayer bags speedy US approval for lymphoma drug Aliqopa

Bayer symbolFDA decision sets the pharma firm up for a showdown with Gilead's Zydelig

Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen flagOffers prospect of lower-cost alternative to Roche's Avastin

Sandoz says Humira biosimilar clears clinical hurdle

Sandoz NovartisIts drug matches the safety and efficacy of AbbVie’s plaque psoriasis blockbuster

GSK's Shingrix sails through FDA advisory committee

GSK - logo on buildingShingles vaccine data proved safe and effective, says the panel

Roche faces prospect of second Rituxan biosimilar in US

RocheFDA begins its review of Sandoz's version of the immunotherapy treatment

GSK preps COPD filing for asthma pioneer Nucala

GSK GlaxoSmithKline houseMoves despite reporting mixed data for the treatment earlier this year

PuzzleForming a picture of health

As life expectancy increases how can stakeholders ensure the last decades of life are healthy ones?

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
inVentiv Health Communications

inVentiv Health Communications brings together best-in-class agencies across advertising, digital, public relations, medical communications, research, market access and clinical trial...

Latest intelligence

Biosimilars: what the future looks like
Biosimilars: what the future looks like...
Tightening medical device safety
European legislators seek to reduce patient exposure to safety risks...
Research Partnership has published a new Living with Ulcerative Colitis (UC) US market report for 2017